These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 28666839)
1. Dopamine transporter (DAT1/SLC6A3) polymorphism and the association between being born small for gestational age and symptoms of ADHD. Waldie KE; Cornforth CM; Webb RE; Thompson JMD; Murphy R; Moreau D; Slykerman R; Morgan AR; Ferguson LR; Mitchell EA Behav Brain Res; 2017 Aug; 333():90-97. PubMed ID: 28666839 [TBL] [Abstract][Full Text] [Related]
2. Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample. Laucht M; Skowronek MH; Becker K; Schmidt MH; Esser G; Schulze TG; Rietschel M Arch Gen Psychiatry; 2007 May; 64(5):585-90. PubMed ID: 17485610 [TBL] [Abstract][Full Text] [Related]
3. A 40-bp VNTR polymorphism in the 3'-untranslated region of DAT1/SLC6A3 is associated with ADHD but not with alcoholism. Šerý O; Paclt I; Drtílková I; Theiner P; Kopečková M; Zvolský P; Balcar VJ Behav Brain Funct; 2015 Jun; 11():21. PubMed ID: 26058807 [TBL] [Abstract][Full Text] [Related]
4. Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype. Bellgrove MA; Hawi Z; Kirley A; Gill M; Robertson IH Neuropsychologia; 2005; 43(13):1847-57. PubMed ID: 16168728 [TBL] [Abstract][Full Text] [Related]
5. Influence of DAT1 and COMT variants on neural activation during response inhibition in adolescents with attention-deficit/hyperactivity disorder and healthy controls. van Rooij D; Hoekstra PJ; Bralten J; Hakobjan M; Oosterlaan J; Franke B; Rommelse N; Buitelaar JK; Hartman CA Psychol Med; 2015 Nov; 45(15):3159-70. PubMed ID: 26073896 [TBL] [Abstract][Full Text] [Related]
6. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder. Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773 [TBL] [Abstract][Full Text] [Related]
7. Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample. Cornish KM; Manly T; Savage R; Swanson J; Morisano D; Butler N; Grant C; Cross G; Bentley L; Hollis CP Mol Psychiatry; 2005 Jul; 10(7):686-98. PubMed ID: 15809660 [TBL] [Abstract][Full Text] [Related]
8. Dopamine transporter gene moderates response to behavioral parent training in children with ADHD: a pilot study. van den Hoofdakker BJ; Nauta MH; Dijck-Brouwer DA; van der Veen-Mulders L; Sytema S; Emmelkamp PM; Minderaa RB; Hoekstra PJ Dev Psychol; 2012 Mar; 48(2):567-74. PubMed ID: 22182296 [TBL] [Abstract][Full Text] [Related]
9. Dopamine transporter genotype conveys familial risk of attention-deficit/hyperactivity disorder through striatal activation. Durston S; Fossella JA; Mulder MJ; Casey BJ; Ziermans TB; Vessaz MN; VAN Engeland H J Am Acad Child Adolesc Psychiatry; 2008 Jan; 47(1):61-67. PubMed ID: 18174826 [TBL] [Abstract][Full Text] [Related]
10. Association study and a systematic meta-analysis of the VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention-deficit hyperactivity disorder. Grünblatt E; Werling AM; Roth A; Romanos M; Walitza S J Neural Transm (Vienna); 2019 Apr; 126(4):517-529. PubMed ID: 30923918 [TBL] [Abstract][Full Text] [Related]
11. Interaction of dopamine transporter gene and observed parenting behaviors on attention-deficit/hyperactivity disorder: a structural equation modeling approach. Li JJ; Lee SS J Clin Child Adolesc Psychol; 2013; 42(2):174-86. PubMed ID: 23153115 [TBL] [Abstract][Full Text] [Related]
12. Evidence of an association between 10/10 genotype of DAT1 and endophenotypes of attention deficit/hyperactivity disorder. Agudelo JA; Gálvez JM; Fonseca DJ; Mateus HE; Talero-Gutiérrez C; Velez-Van-Meerbeke A Neurologia; 2015 Apr; 30(3):137-43. PubMed ID: 24461309 [TBL] [Abstract][Full Text] [Related]
13. Interaction of dopamine transporter (DAT1) genotype and maltreatment for ADHD: a latent class analysis. Li JJ; Lee SS J Child Psychol Psychiatry; 2012 Sep; 53(9):997-1005. PubMed ID: 22646917 [TBL] [Abstract][Full Text] [Related]
14. Dopamine and serotonin transporter genotypes moderate sensitivity to maternal expressed emotion: the case of conduct and emotional problems in attention deficit/hyperactivity disorder. Sonuga-Barke EJ; Oades RD; Psychogiou L; Chen W; Franke B; Buitelaar J; Banaschewski T; Ebstein RP; Gil M; Anney R; Miranda A; Roeyers H; Rothenberger A; Sergeant J; Steinhausen HC; Thompson M; Asherson P; Faraone SV J Child Psychol Psychiatry; 2009 Sep; 50(9):1052-63. PubMed ID: 19490304 [TBL] [Abstract][Full Text] [Related]
15. Dopaminergic haplotype as a predictor of spatial inattention in children with attention-deficit/hyperactivity disorder. Bellgrove MA; Johnson KA; Barry E; Mulligan A; Hawi Z; Gill M; Robertson I; Chambers CD Arch Gen Psychiatry; 2009 Oct; 66(10):1135-42. PubMed ID: 19805704 [TBL] [Abstract][Full Text] [Related]